Subscribe to RSS - home infusion

home infusion

BioScrip revenues are down, but core product mix is up

 - 
08/11/2017

DENVER – BioScrip’s net revenues decreased 6.2% in the second quarter of 2017, but CEO Dan Greenleaf said in an earnings call the company was hitting targets.

BioScrip’s losses rack up in Q2

 - 
08/08/2017

DENVER – BioScrip reported net revenues of $218.1 million for the second quarter of 2017 compared to $232.4 million for the same period a year ago. Net loss was $29.2 million vs. $8.2 million.

Home infusion stakeholders turn to Senate

‘We’re hoping this moves quickly, but there is a sense of healthcare fatigue’
 - 
08/04/2017

WASHINGTON – Home infusion stakeholders are "redoubling" their efforts to fix a payment gap now that a Senate bill has been introduced.

In brief: Temporary payment for home infusion passes House, Stratice partners with athenahealth

 - 
07/28/2017

WASHINGTON – A bill that reforms several Medicare benefits, including home infusion and O&P, sailed through the House of Representatives last week.

Temporary payment for home infusion passes House

 - 
07/26/2017

WASHINGTON – A bill that reforms several Medicare benefits, including home infusion and O&P, sailed through the House of Representatives this week.

Hearing drums up support for home infusion, diabetes bills

 - 
07/21/2017

WASHINGTON – Bills related to home infusion and diabetes supplies were front and center during a hearing last week by the Energy & Commerce Subcommittee on Health in the House of Representatives.

Bill would fix payment gap for home infusion

 - 
07/11/2017

WASHINGTON – Reps. Pat Tiberi, R-Ohio, and Bill Pascrell, D-N.J., have introduced a bill that would create a “temporary transitional payment” for home infusion drugs beginning Jan. 1, 2019.

MSD buys Attentus Medical

 - 
06/15/2017

STOUGHTON, Mass.

Bill seeks to clarify compounding provisions

 - 
06/15/2017

ALEXANDRIA, Va. – Reps. Morgan Griffith, R-Va., and Henry Cuellar, D-Texas, have introduced a bill in the House of Representatives that would clarify congressional intent on several compounding provisions included in the Drug Quality and Security Act of 2013.

Diplomat Specialty Infusion expands into parenteral nutrition

 - 
06/07/2017

URBANDALE, Iowa – Diplomat Specialty Infusion Group, a home infusion pharmacy, has added a sterile compounding environment to its Iowa location, paving the way for it to provide parenteral nutrition therapies.

Pages